AmCad BioMed Corporation announced a private placement to issue 10,000,000 common shares at an issue price of TWD 10 per share for the gross proceeds of TWD 100,000,000 on June 7, 2024. The transaction has been approved by shareholders of company. The company has disclosed the payment period of original shareholders and employees is from July 12, 2024 to July 18, 2024 specific persons from July 19 2024 to July 23, 2024.

The capital injection and issuance of new shares has been approved by the Financial Supervisory Commission in its letter No. Jin-Guan-Zheng-Fa-Zhi 1130343354.